Bladder Cancer Trial, Recruiting (NCT07111364)

Bladder Cancer Trial, Recruiting NCT07111364 Sponsor: Peking University First Hospital Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07111364 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older and a possible bladder growth has been spotted on an ultrasound scan of your abdomen
You are already planned to have surgery to treat a bladder tumour

Who may not be able to join:

You are older than 85 years of age
You are unable to have an ultrasound scan of your abdomen or rectum — for example, if you are unable to cooperate with the procedure or the images produced are not clear enough
You have had surgery, radiotherapy, chemotherapy, or other medical treatment for a bladder tumour within the last 3 months
You have a medical device currently fitted inside your body, such as a ureteral stent (a small tube placed in the urinary tract) or a urinary catheter (a tube used to drain urine)
You do not go on to have bladder tumour surgery within 2 weeks of having your ultrasound scan
Your tumour turns out not to be a specific type called urothelial carcinoma, or your diagnosis has not been confirmed by laboratory testing of tissue (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 139 0137 1490

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07111364

Sponsor: Peking University First Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +86 139 0137 1490

More information: https://clinicaltrials.gov/study/NCT07111364

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older and a possible bladder growth has been spotted on an ultrasound scan of your abdomen
You are already planned to have surgery to treat a bladder tumour

Who may not be able to join:

You are older than 85 years of age
You are unable to have an ultrasound scan of your abdomen or rectum — for example, if you are unable to cooperate with the procedure or the images produced are not clear enough
You have had surgery, radiotherapy, chemotherapy, or other medical treatment for a bladder tumour within the last 3 months
You have a medical device currently fitted inside your body, such as a ureteral stent (a small tube placed in the urinary tract) or a urinary catheter (a tube used to drain urine)
You do not go on to have bladder tumour surgery within 2 weeks of having your ultrasound scan
Your tumour turns out not to be a specific type called urothelial carcinoma, or your diagnosis has not been confirmed by laboratory testing of tissue (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking University First Hospital

Registry

ClinicalTrials.gov

Start date

27 May 2025

Est. completion

1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Diagnostic Accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov